Related Experiment Video
Updated: Jul 2, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Lipid nanocarriers as innovative strategies for hair regrowth
Rabab Kamel1, Shimaa K Mohamed2, Mona M AbouSamra3
1Pharmaceutical Technology Department, National Research Centre, Cairo, 12622, Egypt. drrababk@hotmail.com.
Abstract:
Alopecia, or hair loss, is a multifactorial condition that may arise from genetic, hormonal, or autoimmune causes. This review outlines the major types of alopecia and discusses their underlying etiologies, along with the limitations associated with current therapeutic approaches, including poor efficacy, adverse effects, and low patient adherence. In recent years, lipid-based nanoparticles have emerged as promising carriers for improving the delivery of therapeutic agents to the scalp and hair follicles. The present review summarizes different treatment strategies for alopecia while highlighting the potential role of lipid-based nanocarriers in enhancing drug delivery. The review critically summarizes recent advances in the use of these nanocarriers for alopecia management, with focus on their ability to improve skin penetration, follicular targeting, drug stability, and sustained release characteristics. In addition, the advantages and limitations of different lipid-based systems are comparatively discussed, together with current challenges related to formulation stability, large-scale production, safety, and regulatory considerations in dermatological nanomedicine. Overall, this review provides an updated perspective on the therapeutic potential and translational prospects of lipid based nanocarriers as emerging platforms for alopecia treatment, while highlighting the need for further preclinical and clinical validation.
Insights
Lipid-based nanocarriers show promise for enhancing alopecia treatments by improving drug delivery to hair follicles. Further research is needed to validate their safety and efficacy for hair loss management.
Area of Science:
- Dermatology
- Nanomedicine
- Pharmacology
Background:
- Alopecia (hair loss) has diverse causes including genetic, hormonal, and autoimmune factors.
- Current alopecia treatments face limitations such as poor efficacy, side effects, and low patient adherence.
- Lipid-based nanoparticles offer a novel approach for improved therapeutic agent delivery to the scalp and hair follicles.
Purpose of the Study:
- To review current alopecia treatment strategies.
- To highlight the potential of lipid-based nanocarriers in enhancing drug delivery for alopecia.
- To summarize recent advances and challenges in nanocarrier-based alopecia management.
Main Methods:
- Comprehensive literature review of alopecia treatments.
- Analysis of lipid-based nanocarrier systems for dermatological applications.
- Critical evaluation of nanocarrier properties like skin penetration, follicular targeting, and drug release.
Main Results:
- Lipid-based nanocarriers demonstrate potential for improved skin penetration and follicular targeting.
- These nanocarriers can enhance drug stability and enable sustained drug release.
- Various lipid-based systems offer different advantages and limitations for alopecia treatment.
Conclusions:
- Lipid-based nanocarriers represent a promising platform for advancing alopecia treatment.
- Further preclinical and clinical validation is essential to realize the translational prospects of these nanocarriers.
- Addressing formulation stability, production, safety, and regulatory aspects is crucial for dermatological nanomedicine.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Bioavailability Enhancement: Drug Permeability Enhancement
Accessory Structures of the Skin: Hair Growth and Types
